| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8739026 | International Journal of Infectious Diseases | 2018 | 23 Pages |
Abstract
There is poor guideline adherence to vancomycin prescribing as empirical therapy and at 72-h reassessment in patients with NF. Further efforts are needed to foster a more rational use of vancomycin in patients with NF.
Related Topics
Life Sciences
Immunology and Microbiology
Applied Microbiology and Biotechnology
Authors
Daniel B. Chastain, Sarah Wheeler, Carlos Franco-Paredes, Babatunde Olubajo, W. Anthony Hawkins,